Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 3 , Pages 415-431 , June 2008

Polymorphisms in the IGF1 and IGF1R genes and children born small for gestational age: results of large population studies

  • W.A. Ester, MD (Research Physician in Pediatric Endocrinology & Resident in Clinical Genetics)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: + 31 10 4088292; Fax: + 31 10 4089382.
    • ,
  • A.C.S. Hokken-Koelega, MD, PhD (Professor in Pediatric Endocrinology)

References 

  1. Baker J, Liu JP, Robertson EJ, et al. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73–82
  2. Liu JP, Baker J, Perkins AS, et al. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf1) and type 1 IGF receptor (Igf1r). Cell. 1993;75:59–72
  3. Lee PA, Chernausek SD, Hokken-Koelega AC, et al. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24–October 1, 2001. Pediatrics. 2003;111:1253–1261
  4. Soscia SJ, Tong M, Xu XJ, et al. Chronic gestational exposure to ethanol causes insulin and IGF resistance and impairs acetylcholine homeostasis in the brain. Cellular and Molecular Life Sciences: CMLS. 2006;63:2039–2056
  5. Arends NJ, Boonstra VH, Hokken-Koelega AC. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age. Pediatrics. 2004;114:683–690
  6. Arends NJ, Boonstra VH, Duivenvoorden HJ, et al. Reduced insulin sensitivity and the presence of cardiovascular risk factors in short prepubertal children born small for gestational age (SGA). Clinical Endocrinology. 2005;62:44–50
  7. Boonstra VH, Arends NJ, Stijnen T, et al. Food intake of children with short stature born small for gestational age before and during a randomized GH trial. Hormone Research. 2006;65:23–30
  8. Leger J, Garel C, Fjellestad-Paulsen A, et al. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal. The Journal of Clinical Endocrinology and Metabolism. 1998;83:3512–3516
  9. Forsen T, Eriksson JG, Tuomilehto J, et al. Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study. BMJ (Clinical Research Ed.). 1999;319:1403–1407
  10. Li HJ, Ji CY, Wang W, et al. A twin study for serum leptin, soluble leptin receptor, and free insulin-like growth factor-I in pubertal females. The Journal of Clinical Endocrinology and Metabolism. 2005;90:3659–3664
  11. Verhaeghe J, Loos R, Vlietinck R, et al. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in cord serum of twins: genetic versus environmental regulation. American Journal of Obstetrics and Gynecology. 1996;175:1180–1188
  12. Harrela M, Koistinen H, Kaprio J, et al. Genetic and environmental components of interindividual variation in circulating levels of IGF1, IGF1I, IGFBP-1, and IGFBP-3. The Journal of Clinical Investigation. 1996;98:2612–2615
  13. Hong Y, Pedersen NL, Brismar K, et al. Quantitative genetic analyses of insulin-like growth factor I (IGF1), IGF-binding protein-1, and insulin levels in middle-aged and elderly twins. The Journal of Clinical Endocrinology and Metabolism. 1996;81:1791–1797
  14. Wall JD, Pritchard JK. Haplotype blocks and linkage disequilibrium in the human genome. Nature Reviews. Genetics. 2003;4:587–597
  15. Smith PJ, Spurrell EL, Coakley J, et al. An exonic splicing enhancer in human IGF1 pre-mRNA mediates recognition of alternative exon 5 by the serine-arginine protein splicing factor-2/alternative splicing factor. Endocrinology. 2002;143:146–154
  16. Goldspink G. Mechanical signals, IGF1 gene splicing, and muscle adaptation. Physiology (Bethesda, Md.). 2005;20:232–238
  17. Goldspink G. Changes in muscle mass and phenotype and the expression of autocrine and systemic growth factors by muscle in response to stretch and overload. Journal of Anatomy. 1999;194:323–334
  18. Zhao J, Xiong DH, Guo Y, et al. Polymorphism in the insulin-like growth factor 1 gene is associated with age at menarche in caucasian females. Human Reproduction (Oxford, England). 2007;22:1789–1794
  19. Lettre G, Butler JL, Ardlie KG, et al. Common genetic variation in eight genes of the GH/IGF1 axis does not contribute to adult height variation. Human Genetics. 2007;122:129–139
  20. Johnston LB, Dahlgren J, Leger J, et al. Association between insulin-like growth factor I (IGF1) polymorphisms, circulating IGF1, and pre- and postnatal growth in two European small for gestational age populations. The Journal of Clinical Endocrinology and Metabolism. 2003;88:4805–4810
  21. Vaessen N, Janssen JA, Heutink P, et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet. 2002;359:1036–1037
  22. te Velde SJ, van Rossum EF, Voorhoeve PG, et al. An IGF1 promoter polymorphism modifies the relationships between birth weight and risk factors for cardiovascular disease and diabetes at age 36. BMC Endocrine Disorders. 2005;5:5
  23. Frayling TM, Hattersley AT, McCarthy A, et al. A putative functional polymorphism in the IGF1 gene: association studies with type 2 diabetes, adult height, glucose tolerance, and fetal growth in U.K. populations. Diabetes. 2002;51:2313–2316
  24. Day IN, King TH, Chen XH, et al. Insulin-like growth factor-I genotype and birthweight. Lancet. 2002;360:945;[author reply 946]
  25. Geelhoed JJ, Mook-Kanamori DO, Witteman JC, et al. Variation in the IGF1 gene and growth in foetal life and infancy. The Generation R Study. Clinical Endocrinology. 2007;68(3):382–389
  26. Kinoshita Y, Kizaki Z, Ishihara Y, et al. The relationship in Japanese infants between a genetic polymorphism in the promoter region of the insulin-like growth factor I gene and the plasma level. Neonatology. 2007;92:116–119
  27. Arends N, Johnston L, Hokken-Koelega A, et al. Polymorphism in the IGF1 gene: clinical relevance for short children born small for gestational age (SGA). The Journal of Clinical Endocrinology and Metabolism. 2002;87:2720
  28. Rietveld I, Janssen JA, van Rossum EF, et al. A polymorphic CA repeat in the IGF1 gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clinical Endocrinology. 2004;61:195–203
  29. Vaessen N, Heutink P, Janssen JA, et al. A polymorphism in the gene for IGF1: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes. 2001;50:637–642
  30. Voorhoeve PG, van Rossum EF, Te Velde SJ, et al. Association between an IGF1 gene polymorphism and body fatness: differences between generations. European Journal of Endocrinology. 2006;154:379–388
  31. Rietveld I, Janssen JA, Hofman A, et al. A polymorphism in the IGF1 gene influences the age-related decline in circulating total IGF1 levels. European Journal of Endocrinology. 2003;148:171–175
  32. Francke U, Yang-Feng TL, Brissenden JE, et al. Chromosomal mapping of genes involved in growth control. Cold Spring Harbor Symposia on Quantitative Biology. 1986;51:855–866
  33. Abbott AM, Bueno R, Pedrini MT, et al. Insulin-like growth factor I receptor gene structure. The Journal of Biological Chemistry. 1992;267:10759–10763
  34. Chernausek SD, Jacobs S, Van Wyk JJ. Structural similarities between human receptors for somatomedin C and insulin: analysis by affinity labeling. Biochemistry. 1981;20:7345–7350
  35. Cooke DW, Bankert LA, Roberts CT, et al. Analysis of the human type I insulin-like growth factor receptor promoter region. Biochemical and Biophysical Research Communications. 1991;177:1113–1120
  36. Deming SL, Ren Z, Wen W, et al. Genetic variation in IGF1, IGF1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study. Breast Cancer Research and Treatment. 2007;104:309–319
  37. Bonafe M, Barbieri M, Marchegiani F, et al. Polymorphic variants of insulin-like growth factor I (IGF1) receptor and phosphoinositide 3-kinase genes affect IGF1 plasma levels and human longevity: cues for an evolutionarily conserved mechanism of life span control. The Journal of Clinical Endocrinology and Metabolism. 2003;88:3299–3304
  38. Gunnell D, Lewis S, Wilkinson J, et al. IGF1, growth pathway polymorphisms and schizophrenia: a pooling study. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics. 2007;144:117–120
  39. San Millan JL, Corton M, Villuendas G, et al. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. The Journal of Clinical Endocrinology and Metabolism. 2004;89:2640–2646
  40. Rasmussen SK, Lautier C, Hansen L, et al. Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism. 2000;85:1606–1610
  41. Balding DJ. A tutorial on statistical methods for population association studies. Nature Reviews. Genetics. 2006;7:781–791
  42. Perneger TV. What's wrong with Bonferroni adjustments. BMJ (Clinical Research Ed.). 1998;316:1236–1238
  43. Cardon LR, Palmer LJ. Population stratification and spurious allelic association. Lancet. 2003;361:598–604
  44. Eerligh P, Roep BO, Giphart MJ, et al. Insulin-like growth factor 1 promoter polymorphism influences insulin gene variable number of tandem repeat-associated risk for juvenile onset type 1 diabetes. Tissue Antigens. 2004;63:568–571
  45. Rivadeneira F, van Meurs JB, Kant J, et al. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women. Journal of Bone and Mineral Research. 2006;21:1443–1456
  46. Brzozowski AM, Dodson EJ, Dodson GG, et al. Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry. 2002;41:9389–9397
  47. Sayle RA, Milner-White EJ. RASMOL: biomolecular graphics for all. Trends in Biochemical Sciences. 1995;20:374
  48. Munshi S, Hall DL, Kornienko M, et al. Structure of apo, unactivated insulin-like growth factor-1 receptor kinase at 1.5 A resolution. Acta Crystallographica. Section D, Biological Crystallography. 2003;59:1725–1730

PII: S1521-690X(08)00037-7

doi: 10.1016/j.beem.2008.03.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 22, Issue 3 , Pages 415-431 , June 2008

Article Tools

* Image Usage & Resolution